Centessa Pharmaceuticals (CNTA) Return on Sales: 2022-2025
Historic Return on Sales for Centessa Pharmaceuticals (CNTA) over the last 3 years, with Sep 2025 value amounting to -35.97%.
- Centessa Pharmaceuticals' Return on Sales fell 5181.00% to -35.97% in Q3 2025 from the same period last year, while for Sep 2025 it was -35.97%, marking a year-over-year decrease of 5181.00%. This contributed to the annual value of 23.37% for FY2024, which is 4541.00% up from last year.
- Per Centessa Pharmaceuticals' latest filing, its Return on Sales stood at -35.97% for Q3 2025, which was down 10.55% from -32.54% recorded in Q2 2025.
- Over the past 5 years, Centessa Pharmaceuticals' Return on Sales peaked at 29.71% during Q4 2022, and registered a low of -35.97% during Q3 2025.
- For the 3-year period, Centessa Pharmaceuticals' Return on Sales averaged around 4.28%, with its median value being 15.48% (2024).
- Per our database at Business Quant, Centessa Pharmaceuticals' Return on Sales surged by 811bps in 2024 and then plummeted by 5,181bps in 2025.
- Over the past 4 years, Centessa Pharmaceuticals' Return on Sales (Quarterly) stood at 29.71% in 2022, then slumped by 1,446bps to 15.25% in 2023, then skyrocketed by 811bps to 23.37% in 2024, then tumbled by 5,181bps to -35.97% in 2025.
- Its last three reported values are -35.97% in Q3 2025, -32.54% for Q2 2025, and -30.09% during Q1 2025.